Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study

BACKGROUND: Teriparatide (recombinant human parathyroid hormone 1–34) is increasingly used for the treatment of severe osteoporosis because it stimulates bone formation and may potentially enhance fracture healing. The objective of this study was to investigate the effects of teriparatide versus a b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Musculoskelet Disord
Egile Nagusiak: Iwata, Akira, Kanayama, Masahiro, Oha, Fumihiro, Hashimoto, Tomoyuki, Iwasaki, Norimasa
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384154/
https://ncbi.nlm.nih.gov/pubmed/28388910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-017-1509-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak